Clinical Trial Update: Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650) [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of MK-8242 in participants with advanced solid tumors; trial terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MK-8242

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2016-05-23